317
On 20 February 2006, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 357. The active ingredient is 2’-O-methyl-phosphorothioate oligonucleotide for treatment of Duchenne muscular dystrophy.